Correlation Between Virax Biolabs and Revelation Biosciences

Can any of the company-specific risk be diversified away by investing in both Virax Biolabs and Revelation Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virax Biolabs and Revelation Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Virax Biolabs Group and Revelation Biosciences, you can compare the effects of market volatilities on Virax Biolabs and Revelation Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virax Biolabs with a short position of Revelation Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virax Biolabs and Revelation Biosciences.

Diversification Opportunities for Virax Biolabs and Revelation Biosciences

0.72

Correlation Coefficient

Virax Biolabs  Revelation Biosciences

Poor diversification

The 3 months correlation between Virax and Revelation is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Virax Biolabs Group and Revelation Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Revelation Biosciences and Virax Biolabs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virax Biolabs Group are associated (or correlated) with Revelation Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Revelation Biosciences has no effect on the direction of Virax Biolabs i.e., Virax Biolabs and Revelation Biosciences go up and down completely randomly.

Pair Corralation between Virax Biolabs and Revelation Biosciences

Given the investment horizon of 90 days Virax Biolabs Group is expected to under-perform the Revelation Biosciences. In addition to that, Virax Biolabs is 1.73 times more volatile than Revelation Biosciences. It trades about -0.1 of its total potential returns per unit of risk. Revelation Biosciences is currently generating about -0.07 per unit of volatility. If you would invest  106.00  in Revelation Biosciences on September 2, 2024 and sell it today you would lose (30.00) from holding Revelation Biosciences or give up 28.3% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Virax Biolabs Group  vs.  Revelation Biosciences

Virax Biolabs Group

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Virax Biolabs Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Revelation Biosciences

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Revelation Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Virax Biolabs and Revelation Biosciences

The main advantage of trading using opposite Virax Biolabs and Revelation Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virax Biolabs position performs unexpectedly, Revelation Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Revelation Biosciences will offset losses from the drop in Revelation Biosciences' long position.

The idea behind Virax Biolabs Group and Revelation Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.